Atlas Trials

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT04533581 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04533581
Sponsor
Kyowa Kirin Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Indolent B-cell Non-Hodgkin's Lymphoma
Start date
2020-09-17
Primary completion
2028-05-31
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.